| (210) | Number of the EPO application | 16702654 |
| (220) | Filing date of the EPO application | 2016.01.22 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2019, 2019.11.20 |
| (110) | EPO patent number | 3250575 |
| (11) | Number of the document | MD 3250575 T2 |
| (21) | Number of the application | e 2017 0309 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
| (72) | Name(s) of inventor(s), code of the country | COATES David Andrew, US;
WOLFANGEL Craig Daniel, US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
| (54) | Title of the invention | Tosylate salt of N-[3-[(4aR,7aS)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluoro-phenyl]-5-methoxy-pyrazine-2-carboxamide. |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 513/04 (2006.01.01); A61K 31/542 (2006.01.01); A61P 25/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.02.28 |
| (49) | Date of publication of the translation of the validated European patent specification | 2020.03.31 |
| (30) | Priority | 201562109733 P, 2015.01.30, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2016/014423, 2016.01.22 |
| (87) | International publication | WO 2016/122968, 2016.08.04 |